🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, dose escalation study in patients with advan...
Status
Completed
Location
Next Oncology
Start Date
2020-09-23
Trial ID
NCT04501276
Treatments Being Tested
The purpose of this study is to determine if BMS-663513 administered in com...
Status
Withdrawn
Location
Local Institution
Start Date
2010-11
Trial ID
NCT00803374
The purpose of this Pilot Study is to investigate the safety, side effects,...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2016-03-08
Trial ID
NCT02652455
The study of LVGN6051-201 is designed to use a bridging dose escalation to ...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2021-05-14
Trial ID
NCT04694781
Treatments Being Tested
This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-03-28
Trial ID
NCT02451982
Treatments Being Tested
The goal of this clinical research study is to learn if utomilumab, when gi...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2018-04-04
Trial ID
NCT03258008
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of multi...
Status
Terminated
Location
University Of Pennsylvania Medical Center
Start Date
2007-09
Trial ID
NCT00351325
Treatments Being Tested
LVGN7409 is a humanized monoclonal antibody that specifically binds to CD40...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2020-12-11
Trial ID
NCT04635995
Treatments Being Tested
The purpose of this study is to determine the optimal dose of AGEN2373 that...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2025-05-27
Trial ID
NCT06782932
Treatments Being Tested
This is an open, multi-center, multi-cohort phase I clinical study designed...
Status
Recruiting
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2025-05-27
Trial ID
NCT06410131
Treatments Being Tested